Skip to main content
SpringerLink
Log in

Complications and Side Effects of Oocyte Donation

  • Chapter
Principles of Oocyte and Embryo Donation

Abstract

Oocyte donation represents a special case in the treatment of infertility since it involves some degree of risk to an otherwise uninvolved party: the oocyte donor. This differs considerably from sperm donors, who are at little or no physical risk from the donation process. Therefore, it is important to understand the potential complications affecting a donor and have them explained fully in the informed consent process. One must also take care in applying data from the in vitro fertilization (IVF) literature to oocyte donors, as it appears that donors may not be at the same risk from the IVF process as infertile IVF patients. In addition, some of the purported risks are theoretical, while others may not yet be apparent.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Morris RS, Sauer MV. Oocyte donation in the 1990s and beyond. Assist Reprod Rev. 1993; 3: 211–217.

    Google Scholar 

  2. Rosenberg H, Epstein Y. Follow-up study of anonymous ovum donors. Hum Reprod. 1995; 10: 2741–2747.

    PubMed  CAS  Google Scholar 

  3. Physicians’ Desk Reference. 49th ed. Montvale, NJ: Medical Economics Data Production Company; 1995: 2502–2503.

    Google Scholar 

  4. Friedman AJ, Juneau-Norcross M, Rein MS. Adverse effects of leuprolide acetate depot treatment. Fertil Steril. 1993; 59: 448–450.

    PubMed  CAS  Google Scholar 

  5. Johansen JS, Riis BJ, Hassager C, et al. The effect of a gonadotropin releasing hormone analog (nafarelin) on bone metabolism. J Clin Endocrinol Metab. 1988; 67: 701–706.

    Article  PubMed  CAS  Google Scholar 

  6. Hodgen GD. General applications of GnRH agonists in gynecology: past, present, and future. Obstet Gynecol Surv. 1989; 44: 293–296.

    Article  PubMed  CAS  Google Scholar 

  7. Feldberg D, Ashkenazi J, Dicker D, et al. Ovarian cyst formation: a complication of gonadotropin releasing hormone therapy. Fertil Steril. 1989: 51: 42–45.

    PubMed  CAS  Google Scholar 

  8. Ben-Rafael Z, Bider D, Menashe Y, Maymon R, Zolti M, Mashiach S. Follicular and luteal cysts after treatment with gonadotropin releasing hormone analog for in vitro fertilization. Fertil Steril. 1990; 53: 1091–1094.

    PubMed  CAS  Google Scholar 

  9. Droesch K, Barbieri RL. Ovarian hyperstimulation syndrome associated with the use of the gonadotropin releasing hormone agonist leuprolide acetate. Fertil Steril. 1994; 62: 189–190.

    PubMed  CAS  Google Scholar 

  10. Meldrum DR, Wisot A, Hamilton F, et al. Timing of initiation and dose schedule of leuprolide influence the time course of ovarian suppression. Fertil Steril. 1988: 50: 400–402.

    PubMed  CAS  Google Scholar 

  11. Martinez F, Barri PN, Coroleu V. Case report: accidental GnRH agonist administration during early pregnancy. Hum Reprod. 1988; 3: 669.

    PubMed  CAS  Google Scholar 

  12. Wilshire GB, Emmi AM, Gagliardi CC, Weiss GW. Gonadotropin releasing hormone agonist administration in early human pregnancy is associated with normal outcomes. Fertil Steril. 1993; 60: 980–983.

    PubMed  CAS  Google Scholar 

  13. Young DC, Snabes MC, Poindexter AN. GnRH agonist exposure during the first trimester of pregnancy. Obstet Gynecol. 1993; 81: 587–589.

    PubMed  CAS  Google Scholar 

  14. Elefant E, Biour B, Blumberg-Tick J, Roux C, Thomas F. Administration of a gonadotropin releasing hormone agonist during pregnancy: follow-up of 28 pregnancies exposed to triptoreline. Fertil Steril. 1995; 63: 1111–1113.

    PubMed  CAS  Google Scholar 

  15. Fraunfelder FT. Possible ocular adverse effects associated with leuprolide injections. JAMA 1995; 273: 773–774.

    Article  PubMed  CAS  Google Scholar 

  16. Hall LLH, Malone JM, Ginsburg KA. Flare-up of endometriosis induced by gonadotropin releasing hormone agonist leading to bowel obstruction. Fertil Steril. 1995; 64: 1204–1206.

    PubMed  CAS  Google Scholar 

  17. Friedman AJ. Acute urinary retention after gonadotropin releasing hormone agonist treatment for leiomyomata uteri. Fertil Steril. 1993; 59: 677–678.

    PubMed  CAS  Google Scholar 

  18. Ashkenazi J, Goldman JA, Dicker D, Feldberg D, Goldman GA. Adverse neurological symptoms after gonadotropin releasing hormone analog therapy for in vitro fertilization cycles. Fertil Steril. 1990; 53: 738–740.

    PubMed  CAS  Google Scholar 

  19. Newton C, Slota D, Yuzpe AA, Tummon IS. Memory complaints associated with the use of gonadotropin-releasing hormone agonists: a preliminary study. Fertil Steril. 1996; 65: 1253–1255.

    PubMed  CAS  Google Scholar 

  20. Redfearn A, Hughes EG, O’Connor M, Dolovich J. Delayed-type hypersensitivity to human gonadotropin: case report. Fertil Steril. 1995; 64: 855–856.

    PubMed  CAS  Google Scholar 

  21. Li TC, Hindle JE. Adverse local reaction to intramuscular injections of urinary-derived gonadotropins. Hum Reprod. 1993; 8: 1835–1836.

    PubMed  CAS  Google Scholar 

  22. Hurwitz A, Milwidsky A, Yagel S, Adoni A. Early unwinding of torsion in an ovarian cyst as a result of hyperstimulation syndrome. Fertil Steril. 1983; 40: 393–394.

    PubMed  CAS  Google Scholar 

  23. Pryor RA, Wiczyk HP, O’Shea DL. Adnexal infarction after conservative management of torsion of a hyperstimulated ovary. Fertil Steril. 1995; 63: 1344–1346.

    PubMed  CAS  Google Scholar 

  24. Chin NW, Friedman CI, Awadalla SG, Miller FA, Kim MH. Adnexal torsion as a complication of superovulation for ovum retrieval. Fertil Steril. 1987; 48: 149–150.

    PubMed  CAS  Google Scholar 

  25. Narayanan M, Murthy PSR, Munaf SA, Shah LCP, Kini MD. Antiovarian antibodies and their effect on the outcome of assisted reproduction. J Assist Reprod Genet. 1995; 12: 599–605.

    Article  PubMed  CAS  Google Scholar 

  26. Soderstrom-Anttila V. Follow-up study of Finnish volunteer oocyte donors concerning their attitudes to oocyte donation. Hum Reprod. 1995; 10: 3073–3076.

    PubMed  CAS  Google Scholar 

  27. Morris RS, Wong IL, Do YS, et al. The pathophysiology of ovarian hyperstimulation syndrome. A proposal role of the ovarian derived prorenin to angioten-sin cascade (ODPAC). Adv Exp Med Bio. 1995; 377: 391–398.

    CAS  Google Scholar 

  28. Haning RV, Strawn EY, Nolten WE. Pathophysiology of the ovarian hyperstimulation syndrome. Obstet Gynecol. 1985; 66: 220–224.

    PubMed  Google Scholar 

  29. Phillips LL, Gladstone W, Wiele RV. Studies of the coagulation and fibrinolytic systems in hyperstimulation syndrome after administration of human gonadotropins. J Reprod Med. 1975; 14: 138–143.

    PubMed  CAS  Google Scholar 

  30. Kodama H, Fukuda J, Karube H, Matsui T, Shimizu Y, Tanaka T. Status of the coagulation and fibrinolytic systems in ovarian hyperstimulation syndrome. Fertil Steril. 1996; 66: 417–424.

    PubMed  CAS  Google Scholar 

  31. Montgomery Rice VC, Richard-Davis G, Saleh AA, et al. Fibrinolytic parameters in women undergoing ovulation induction. Am J Obstet Gynecol. 1993; 169: 1549–1553.

    PubMed  CAS  Google Scholar 

  32. Kaaja R, Siegberg R, Tiitinen A, Kosimies A. Severe ovarian hyperStimulation syndrome and deep vein thrombosis. Lancet 1989; 2: 1043.

    Article  PubMed  CAS  Google Scholar 

  33. Rizk B, Meagher S, Fisher AM. Severe ovarian hyperstimulation syndrome and cerebrovascular accidents. Hum Reprod. 1990; 5: 697–698.

    PubMed  CAS  Google Scholar 

  34. Coney S. Auckland inquest into death after IVF. Lancet. 1995; 345: 849.

    Article  Google Scholar 

  35. Luxman D, Cohen JR, Gordon D, Wolman I, Wolf Y, David MP. Unilateral vulvar edema associated with paracentesis in patients with ovarian hyperstimulation syndrome. J Reprod Med. 1996; 41: 771–774.

    PubMed  CAS  Google Scholar 

  36. Levin MF, Kaplan BR, Hutton LC. Thoracic manifestations of ovarian hyperstimulation syndrome. Can Assoc Radiol J. 1995; 46: 23–26.

    PubMed  CAS  Google Scholar 

  37. Jewelicz R, Vande Wiele RL. Acute hydrothorax as the only symptom of ovarian hyperstimulation syndrome. Am J Obstet Gynecol. 1975; 121: 1121.

    Google Scholar 

  38. Golan A, Ron-el R, Herman H. Ovarian hyperstimulation syndrome: an update review. Obstet Gynecol Surv. 1989; 44: 430–440.

    Article  PubMed  CAS  Google Scholar 

  39. Morris RS, Paulson RJ, Sauer MV, Lobo RA. Predictive value of serum estradiol concentrations and oocyte number in severe ovarian hyperstimulation syndrome. Hum Reprod. 1995; 10: 811–814.

    Article  PubMed  CAS  Google Scholar 

  40. Sauer MV, Paulson RJ. Mishaps and misfortunes: complications that occur in oocyte donation. Fertil Steril. 1994; 61: 963–965.

    PubMed  CAS  Google Scholar 

  41. Halme J, Toma SK, Talbert LM. A case of severe ovarian hyperstimulation in a healthy oocyte donor. Fertil Steril. 1995; 64: 857–859.

    PubMed  CAS  Google Scholar 

  42. Borlum KG, Maigaard S. Transvaginal oocyte aspiration and pelvic infection [letter]. Lancet. July 1 1989; 2: 53.

    Article  PubMed  CAS  Google Scholar 

  43. Yuzpe AA, Brown SE, Casper RF, Nisker J, Graves G, Shatford L. Transvaginal, ultrasound-guided oocyte retrieval for in vitro fertilization. J Reprod Med. 1989; 34: 937–942.

    PubMed  CAS  Google Scholar 

  44. Howe RS, Wheeler C, Mastroianni L, Blasco L, Tureck R. Pelvic infection after transvaginal ultrasound guided ovum retrieval. Fertil Steril. 1988; 49: 726–728.

    PubMed  CAS  Google Scholar 

  45. Van Os HC, Roozenberg BJ, Janssen-Caspers HS, et al. Vaginal disinfection with povidone iodine and the outcome of in-vitro fertilization. Hum Reprod. 1992; 7: 349–350.

    PubMed  Google Scholar 

  46. Ashkenazi J, Farhi J, Dicker D, Shalev J, Ben-Rafael Z. Acute pelvic inflammatory disease after oocyte retrieval: adverse effects on the results of implantation. Fertil Steril. 1994; 61: 526–528.

    PubMed  CAS  Google Scholar 

  47. Bennett SJ, Waterstone JJ, Cheng WC, Parsons J. Complications of transvaginal ultrasound directed follicle aspiration: a review of 2670 consecutive procedures. J Assist Reprod Genet. 1993; 10: 72–77.

    Article  PubMed  CAS  Google Scholar 

  48. Dicker D, Ashkenazi J, Feldberg D, Levy T, Dekel A, Ben-Rafael Z. Severe abdominal complications after transvaginal ultrasonographically guided retrieval of oocytes for in vitro fertilization and embryo transfer. Fertil Steril. 1993; 59: 1313–1315.

    PubMed  CAS  Google Scholar 

  49. Evers JLH, Larsen JF, Gnany GG, Sieck UV. Complications and problems in transvaginal sector scan-guided follicle aspiration. Fertil Steril. 1988; 49: 278–282.

    PubMed  CAS  Google Scholar 

  50. Cohen J, Debache C, Pez JP, Junca AM, Cohen-Bacrie P. Transvaginal sonographically controlled ovarian puncture for oocyte retrieval for in vitro fertilization. J In Vitro Fert Embryo Transf. 1986; 3: 309–313.

    Article  PubMed  CAS  Google Scholar 

  51. Feichtinger W, Kemeter P. Laparoscopic or ultrasonically guided follicle aspiration for in vitro fertilization. J In Vitro Fert Embryo Transf. 1984; 1: 244–249.

    Article  PubMed  CAS  Google Scholar 

  52. Riddle AF, Sarma V, Mason BA, et al. Two years’ experience of ultrasound directed oocyte retrieval. Fertil Steril. 1987; 48: 454–458.

    PubMed  CAS  Google Scholar 

  53. Ilbery M, Lyons B, Sundaresan V. Ovarian necrotizing vasculitis causing major intra-abdominal hemorrhage after IVF. Case report and literature review. Br J Obstet Gynecol. 1991; 98: 596–599.

    Article  CAS  Google Scholar 

  54. Van Hoorde GJ, Verhoff A, Zeilmaker GH. Perforated appendicitis following transvaginal oocyte retrieval for in-vitro fertilization and embryo transfer. Hum Reprod. 1992; 7: 850–851.

    PubMed  Google Scholar 

  55. Jones WR, Haines CJ, Matthews CD, Kirby CA. Traumatic ureteric obstruction secondary to oocyte recovery for in vitro fertilization: a case report. J In Vitro Fert Embryo Transf. 1985; 6: 185–187.

    Article  Google Scholar 

  56. Amso NN. Role of assisted reproduction in endometriosis. In: Shaw RW, ed. Endometriosis: Current Understanding and Management. Oxford: Blackwell Science; 1985; 282–297.

    Google Scholar 

  57. Amso NN. Potential health hazards of assisted reproduction. Hum Reprod. 1995; 10: 1628–1630.

    PubMed  CAS  Google Scholar 

  58. Whittemore AS, Harris R, Itnyre J, The Collaborative Ovarian Cancer Group. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Am J Epidemiol. 1992; 136: 1184–1203.

    PubMed  CAS  Google Scholar 

  59. Cohen J, Forman R, Harlap S, Johannisson E, Lunenfeld B, de Mouzon J. IFFS expert group report on the Whittemore study related to the risk of ovarian cancer associated with use of fertility agents. Hum Reprod. 1993; 8: 996–999.

    Article  PubMed  CAS  Google Scholar 

  60. Bristow RE, Karlan BY. Ovulation induction, infertility, and ovarian cancer risk. Fertil Steril. 1996; 66: 499–507.

    PubMed  CAS  Google Scholar 

  61. Booth M, Beral V, Smith P. Risk factors for ovarian cancer: case-control study. Br J Cancer. 1989; 60: 592–598.

    Article  PubMed  CAS  Google Scholar 

  62. Joly DJ, Lilienfeld AM, Diamond EL, Bross IDJ. An epidemiologic study of the relationship of reproductive experience to cancer of the ovary. Am J Epidemiol. 1974; 99: 190–209.

    PubMed  CAS  Google Scholar 

  63. Rossing MA, Daling JR, Weiss NS, Moore DE, Self SG. Ovarian tumors in a cohort of infertile women. N Engl J Med. 1994; 331: 771–776.

    Article  PubMed  CAS  Google Scholar 

  64. Hildreth NG, Kelsey JL, Li Volsi VA, Fischer DB, Holford TR, Mostow ED. An epidemiologic study of epithelial carcinoma of the ovary. Am J Epidemiol. 1982; 115: 714–719.

    Google Scholar 

  65. Weiss NS, Lyon JL, Liff JM, Vollmer WM, Daling JR. Incidence of ovarian cancer in relation to the use of oral contraceptives. Int J Cancer. 1981; 28: 669–671.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Randy S. Morris
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Reproductive Endocrinology, Columbia University, College of Physicians and Surgeons Columbia-Presbyterian Medical Center, 622 West 168th Street, PH16-28, New York, NY, 10032-3784, USA

    Mark V. Sauer

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media New York

About this chapter

Cite this chapter

Morris, R.S. (1998). Complications and Side Effects of Oocyte Donation. In: Sauer, M.V. (eds) Principles of Oocyte and Embryo Donation. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-1640-7_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-1640-7_9

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4612-7226-7

  • Online ISBN: 978-1-4612-1640-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation